Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FANCE | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | TMED9 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | TUBGCP4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | C9 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | RNF8 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | NUP133 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | SMU1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | TRA2B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | EPS8L2 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |